SCLX Company Profile and Key Details

Scilex Holding Company generated EPS of -$33.08 over the past year. Five-year average earnings growth is -526.67%. Scilex Holding Company earnings surprise history is a mixed track record. The quarter that ended April 10, 2026, missed forecasts by 878.72%. The prior quarter beat by -31768.14%. Over the last six quarters, Apple has recorded several small beats. These include 150.0% in March 31, 2025.

SCLX has shown weak momentum, losing -18.73% over the past week and -14.79% over the past quarter, though year-to-date performance is down -10.74%. Short-term trend indicators are bullishly aligned (SMA20 -3.16%, SMA50 -26.09%, SMA200 -40.27%). The stock’s 14-day RSI is 36.49 (weak momentum), while the ATR of 0.78 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -76.31% below its high and over 125.56% above its low. Average 10-day trading volume of 151.01 thousand shares is significantly above the 3-month average of 56.58 thousand, indicating heightened recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Scilex Holding Company (NASDAQ:SCLX) closed at $6.82 USD, losing -$0.08 (-1.17%) from the previous close of $6.90. The stock is currently mid-range between its 52-week high and low $3.94 and $34.27. With a market capitalization of about $57.91 million, Scilex Holding Company is classified as a micro-cap and shows higher-than-market volatility (beta ~1.79). Key stats such as the average daily volume over the past year has been around 56.15 thousand shares, volume is running light vs its 52-week average. Headquartered in Palo Alto, CA, Scilex Holding Company operates in the Healthcare sector and the Drug Manufacturers - General industry. Led by CEO Henry H. Ji, the company employs approximately 115 people and listed since March 05, 2021. Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain.

Scilex Holding Company has 6.96 million shares outstanding. The public float is 2.92 million shares, elevated short interest at 10.80% of float. This equals 447.39 thousand shares. The short ratio is 2.05 days. Institutional investors hold 16.35% of the float. Insiders own 17.56%. Scilex Holding Co holds 244.45 million shares, Ji Henry has 2.60 million shares and Ma Stephen Hoi has 650.00 thousand shares. Over the past six months, insider transactions show net selling. They sold 21.31 million shares across 4 transactions.

Scilex Holding Company trades at a P/E ratio of -0.2, slightly below the S&P 500 average, with a price-to-sales ratio of 2.04 and a price-to-book ratio of -0.39 indicating negative book value, which may reflect financial stress. The P/FCF stands at 17.98, also below market averages.

Our AI price prediction model suggests that Scilex Holding Company stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 14.49%, with price expected at $7.90 by May 25, 2026, within a range of $6.48 to $9.33 3-Month Outlook: Projected fall of -73.19%, reaching $1.85 by August 07, 2026, with a range of $0.50 to $2.21. 1-Year Outlook: Projected gain of 72.46%, with price at $11.90 by May 11, 2027, within a range of $0.00 to $2.58.

Scilex Holding Company (NASDAQ:SCLX) shares are down -10.74% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Scilex Holding Company trading at a premium to the broader market with a P/E of -0.2. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $13.33, suggesting 93.19% upside. Our AI forecast model points to short-term strength (14.49% over two weeks), a medium-term fall (-73.19% over three months), and a longer-term gain (72.46% over one year), with expected trading ranges indicating moderate volatility.